- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06862076
Impact of Lung Function Prehabilitation to Postoperative Pulmonary Complications
March 5, 2025 updated by: Dita Aditianingsih, Indonesia University
The Impact of Lung Function Prehabilitation to Postoperative Pulmonary Complications on Patient Undergoing Upper Abdominal Surgery Treated in Intensive Care Unit: A Randomized Controlled Trial
The aim of this study is to compare the effect of lung function prehabilitation to postoperative pulmonary complications on patient undergoing upper abdominal surgery treated in intensive care unit.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Jakarta
-
Jakarta Pusat, Jakarta, Indonesia, 10430
- RSUPN Dr. Cipto Mangunkusumo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- adults 18 years or older
- scheduled for the upper abdominal surgery under general anesthesia with intraoperative mechanical ventilation
- possess adequate cognitive function to comprehend and follow instructions
- possess sufficient physical capacity to perform structured prehabilitation exercises
- express willingness to participate in the intervention program before surgery
Exclusion Criteria:
- pregnancy
- pre-existing severe pulmonary diseases such as chronic obstructive pulmonary disease (COPD)
- planned laparoscopic procedures
- history of significant neuromuscular impairment (e.g: stroke)
- declined to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Lung Function Prehabilitation
Participants assigned to the prehabilitation group received personalized exercise prescriptions, including aerobic training, muscle strengthening, and inspiratory muscle training with a threshold device.
The prehabilitation program was conducted at the participants' homes for a minimum duration of two weeks.
Adherence was monitored through logbook entries and video call evaluations to ensure correct implementation of the prescribed exercises.
|
Participants assigned to the prehabilitation group received personalized exercise prescriptions, including aerobic training, muscle strengthening, and inspiratory muscle training with a threshold device.
The prehabilitation program was conducted at the participants' homes for a minimum duration of two weeks.
Adherence was monitored through logbook entries and video call evaluations to ensure correct implementation of the prescribed exercises.
|
|
No Intervention: Standard of Care
No prehabilitation is done, patients in this group received standard of care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative pulmonary complications
Time Frame: Postoperative day 1 and 3
|
Including pulmonary infections, atelectasis, and diaphragmatic dysfunction.
Pulmonary infection is assessed using the Clinical Pulmonary Infection Score (CPIS) and with a threshold of >6, atelectasis using Lung Ultrasound Score (LUS) of ≥1, and diaphragm ultrasound were used to evaluate diaphragm ratio.
CPIS and LUS score assessments were conducted on postoperative day 1 and 3 by trained investigators, diaphragm ratio assessment was conducted preoperatively and on postoperative day 1 and 3, all findings were systematically recorded.
|
Postoperative day 1 and 3
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2023
Primary Completion (Actual)
June 30, 2024
Study Completion (Actual)
November 12, 2024
Study Registration Dates
First Submitted
March 1, 2025
First Submitted That Met QC Criteria
March 5, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 5, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IndonesiaUAnes049
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Pulmonary Complications (PPCs)
-
Region StockholmKarolinska InstitutetRecruitingPostoperative Pulmonary Complications (PPCs)Sweden
-
Jun ZhangNot yet recruitingPostoperative Pulmonary Complications (PPCs)
-
Jun ZhangCompletedPostoperative Pulmonary Complications (PPCs)China
-
State Budgetary Healthcare Institution, National...CompletedLung Ultrasound | Postoperative Atelectasis | Postoperative Pulmonary Complications (PPCs)Russia
-
Cantonal Hospital of St. GallenNot yet recruitingMechanical Ventilation | Postoperative Pulmonary Complications (PPCs)Switzerland
-
Dr Abdurrahman Yurtaslan Ankara Oncology Training...RecruitingPostoperative Pain Management | Abdominal Surgeries | Postoperative Pulmonary Complications (PPCs)Turkey (Türkiye)
-
Pest County Flór Ferenc HospitalSemmelweis University; Kiskunhalas Semmelweis Hospital the Teaching Hospital...RecruitingMechanical Power | Oxygenation | Postoperative Pulmonary Complications (PPCs)Hungary
-
Bursa City HospitalNot yet recruitingCardiac Surgery | Mechanical Power | Postoperative Pulmonary Complications (PPCs)Turkey (Türkiye)
-
Cantonal Hospital of St. GallenMedical University Innsbruck; University Hospital Bergmannsheil BochumRecruitingFeasibility Studies | Pilot Study | Postoperative Pulmonary Complications (PPCs)Austria, Germany, Switzerland
-
Zhongda HospitalRecruitingCardiac Surgery in Adult Patient | Postoperative Pulmonary Complications (PPCs)China
Clinical Trials on Lung Function Prehabilitation
-
Karolinska University HospitalCompleted
-
Portsmouth Hospitals NHS TrustRecruitingAsthmaUnited Kingdom
-
University of RostockCompletedSARS-CoV-2 InfectionGermany
-
Stefania La Grutta, MDTerminatedAsthma | Allergic RhinitisItaly
-
Hermina HospitalsUniversitas PadjadjaranCompleted
-
University of SouthamptonAssistance Publique - Hôpitaux de Paris; Hacettepe University; Universitaire... and other collaboratorsUnknownPrimary Ciliary DyskinesiaUnited Kingdom
-
Haukeland University HospitalUniversity of BergenUnknown
-
University Hospital Inselspital, BerneActive, not recruitingHealthy | Cystic FibrosisSwitzerland
-
Newcastle-upon-Tyne Hospitals NHS TrustNorthumbria UniversityUnknown